Category Archives: – Pharma

Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome

January 20, 2016- Produced, Interviewed by Steven E. Greer, MD We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his

Posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard | Leave a comment

The Biggest stories of 2015

December 31, 2015- by Steven E. Greer, MD 2015 was the year of ISIS. The radical jihadist group started the year with an attack in France,

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - Reviews, books, devices, - The Weekly Summary | Leave a comment

Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry

September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking

Posted in - Biotech, - Pharma, Congress, FDA | Leave a comment

Rand Paul’s secret Looney Tune side revealed

February 2, 2015- By Steven E. Greer, MD People have asked me my opinion of the Republican field for 2016 and I have told them that Dr. Rand

Posted in - Pharma, Congress, Infectious disease, Pediatrics, Primary care medicine | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment

Using Afrezza inhaled insulin with a CGM

November 3, 2014- Interviewed by Steven E. Greer, MD Inhaled insulin will make a comeback when Mannkind’s drug, Afrezza, goes on sale in early 2015.

Posted in - Pharma, Diabetes and endocrinology, Primary care medicine, Univ Miami | Leave a comment

Oh my god, I have a disease!

March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious

Posted in - Pharma, Congress, FDA | Leave a comment

The serious adverse events caused by topical testoserone

March 1, 2014

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

Industry conflicts arise at PCORI threatening any real comparative effectiveness research

February 7, 2014- By Steven E. Greer, MD The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010.

Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale | Leave a comment

The FDA discusses Brilinta

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal

Posted in - Pharma, Cardiology, FDA | Leave a comment

The serious adverse events caused by antipsychotics

February 1, 2014

Posted in - Pharma, FDA | Leave a comment

Alex Rodriguez’s PED schedule

January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor

Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology | Leave a comment

CBS allows TV doctor to make egregious claims about statins

Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading

Posted in - Pharma, Cardiology, Cedars Sinai | Leave a comment

New therapies for hepatitis C

November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care

Posted in - Biotech, - Pharma, Gastroenterology and liver, Infectious disease, UCLA | Leave a comment

Super rapid acting insulin and inhaled insulin

September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University

Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami | Leave a comment

FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs

Interviewed by Steven E. Greer, MD

Posted in - Pharma, FDA | Leave a comment

anti-PD1 and anti-PD-L1 drugs treating NSCLC

March 26, 2013 Interviewed By Steven E. Greer, MD

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Damon Runyon Cancer Research Foundation panel

March 8, 2013  By Steven E. Greer, MD We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Steven E. Greer, MD, on CNBC discussing antidepressants

Related stories

Posted in - Pharma, FDA, Psychology Psychiatry | Leave a comment

“You’re telling me this now?” Why the news is suddenly critical of statins and antidepressants

Opinion: February 19, 2012  By Steven Greer, MD The CBS news show “60 Minutes” made waves with a story asserting that the antidepressants

Posted in - Opinion, - Pharma, - Policy, Congress, FDA | Leave a comment